MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-08-0010135
I B Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹70.17 Cr
▲ 21% YoY
Net profit · FY 2025
₹1.28 Cr
Net margin 1.8%
EBITDA · FY 2025
₹2.7 Cr
EBITDA margin 3.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.64 Lakh
Issued & subscribed
Open charges
₹25.27 Cr
Satisfied ₹12.87 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
5
Provident fund records
About I B Pharma Private Limited
Data last updated:
I B Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2007PTC166799. Its GSTIN is 07AABCI7368B1ZO (Delhi). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.64 Lakh. It is led by directors Ritu Goyal and Manoj Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.2 Plot No. E – 22, Block – B – 1 Upper Ground Floor Mohan Cooperative Industrial Estate Mathura Road, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.17 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹1.28 Cr (net margin 1.8%) and EBITDA of ₹2.7 Cr (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 13% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ibpharma. As per MCA filings, the company has open charges of ₹25.27 Cr and satisfied charges of ₹12.87 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 1 case is pending.
I B Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0010135). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ibpharma.in.
Company details
CIN U51397DL2007PTC166799
Registration Number 166799
Incorporation Date 08 August 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-08-0010135
Key People
Ritu Goyal Director Manoj Goyal Director Recognitions & Rankings of I B Pharma
Contact details
I B Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is ibpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No.2 Plot No. E – 22, Block – B – 1 Upper Ground Floor Mohan Cooperative Industrial Estate Mathura Road, New Delhi, Delhi, India – 110044
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of I B Pharma Private Limited, buy the company report.
Comprehensive company report
I B Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
I B Pharma operates one associated brand: Ibpharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| ibpharma.in |
Business activity
The main business activity of I B Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of I B Pharma Private Limited, buy the company report.
Financials of I B Pharma Private Limited
FY 2025 filings availableI B Pharma Private Limited reported revenue of ₹70.17 Cr (up 21% YoY) for FY 2025.
Revenue · FY 2025
₹70.17 Cr ▲ 21%
Net profit · FY 2025
₹1.28 Cr margin 1.8%
EBITDA · FY 2025
₹2.7 Cr margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 9%
5 years · compounded
▼ 13%
EBITDA CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 21%
5 years · compounded
▲ 3%
Revenue rose 21% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 13%. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.7 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.28 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of I B Pharma Private Limited, buy the company report.
Board of directors of I B Pharma Private Limited
I B Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritu Goyal | Director | 13 Aug 2020 | 6 Years 2 Months | Current |
| Manoj Goyal | Director | 13 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
I B Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chemsynth Drugs & Pharmaceuticals Private Limited | ₹70.25 Cr (FY 2024) | 29.0% | New Delhi, Delhi, India | |||
| Mishri Medipoint Private Limited | ₹70.23 Cr (FY 2025) | -20.0% | Chennai, Tamil Nadu, India | |||
| I B Pharma Private Limitedthis company | ₹70.17 Cr (FY 2025) | ₹1.28 Cr | 1.8% | 21.0% | 5 | New Delhi, Delhi, India |
| Serge Pharma Private Limited | ₹70.11 Cr (FY 2025) | 31.0% | Indore, Madhya Pradesh, India | |||
| Yatnesh Pharma Private Limited | ₹69.6 Cr (FY 2025) | 42.0% | New Delhi, Delhi, India | |||
| Astellas Pharma India Private Limited | ₹68.97 Cr (FY 2025) | 58.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of I B Pharma Private Limited, buy the company report.
Auditor
I B Pharma Private Limited is audited by For Nitin Mittal & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| For Nitin Mittal & Co. | FY 2023 | 017642N |
Shareholding
The shareholding of I B Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of I B Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25.27 Cr
Satisfied charges
₹12.87 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Aug 2025 | 101154339 | Others | ₹14 Cr | Open | |
| 04 May 2024 | 100925748 | Hdfc Bank Limited | ₹8.6 Cr | Open | |
| 24 Aug 2021 | 100479431 | Hdfc Bank Limited | ₹24.27 Lakh | Open | |
| 27 Jun 2015 | 10583913 | Yes Bank Limited | ₹2.43 Cr | Open | |
| 25 Nov 2022 | 100654165 | Others | ₹1.17 Cr | Satisfied |
To see the full charge records of I B Pharma Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
I B Pharma Private Limited has 4 court cases on record: 4 filed by I B Pharma. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
4
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against Wisdom Pharmaceuticals | Pending |
| District court, South East, Delhi | Commercial suit | Filed by the company against an individual | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against Aahan Pharma and Ors. | Disposed |
| District court, South, Delhi | Criminal case | Filed by the company against M/S Aahan Pharma and Ors | Disposed |
To see the full case history of I B Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for I B Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
I B Pharma Private Limited has a workforce of 5 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
5
Active EPFO establishments
1
Employee growth
-28.57%
GST
I B Pharma has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
6
Active
5
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCI7368B1ZO | Delhi | Active | 01 Jul 2017 |
| 06AABCI7368B1ZQ | Haryana | Active | 01 Jul 2017 |
| 27AABCI7368B1ZM | Maharashtra | Active | 01 Jul 2017 |
| 19AABCI7368B1ZJ | West Bengal | Active | 06 Jun 2023 |
To see the full GST registrations and return filing status of I B Pharma Private Limited, buy the company report.
Recent activity
I B Pharma Private Limited has 8 board changes on record since 2007: 2 appointments and 6 cessations. The latest: Meetu Kansal ceased to be Additional Director on 14 Aug 2020.
AGM
I B Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1,400.00 Lakh with Charge ID 101154339 was registered on 01 Aug 2025.
Filing
I B Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Yes Bank Limited of Rs. 243.00 Lakh registered on 27 Jun 2015 with Charge ID 10583913 was modified on 06 Jan 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 860.00 Lakh with Charge ID 100925748 was registered on 04 May 2024.
Charges
A charge registered on 25 Nov 2022 via Charge ID 100654165 with Others was fully satisfied on 27 Apr 2023.
Charges
A charge registered on 25 Nov 2022 via Charge ID 100654307 with Others was fully satisfied on 27 Apr 2023.
Charges
A charge with Others amounted to Rs. 117.00 Lakh with Charge ID 100654165 was registered on 25 Nov 2022.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100654307 was registered on 25 Nov 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 24.27 Lakh with Charge ID 100479431 was registered on 24 Aug 2021.
Ceased
Meetu Kansal ceased to be Additional Director.
Ceased
Nitin Kansal ceased to be Additional Director.
13 earlier events are in the company report.
Frequently asked questions
I B Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 August 2007 (19+ years old) and is registered under CIN U51397DL2007PTC166799.
I B Pharma has 2 current directors:
- Ritu Goyal - Director
- Manoj Goyal - Director
The latest financial statements of I B Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of I B Pharma is 07AABCI7368B1ZO, registered in Delhi. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 06AABCI7368B1ZQ (Haryana), 27AABCI7368B1ZM (Maharashtra), 19AABCI7368B1ZJ (West Bengal).
The CIN (Corporate Identification Number) of I B Pharma is U51397DL2007PTC166799. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I B Pharma has 4 court cases on record: 4 filed by the company. 1 is pending.
I B Pharma was incorporated on 08 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of I B Pharma by revenue are Chemsynth Drugs & Pharmaceuticals Private Limited, Mishri Medipoint Private Limited, Serge Pharma Private Limited, Yatnesh Pharma Private Limited, Astellas Pharma India Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Meetu Kansal ceased to be Additional Director on 14 Aug 2020. Nitin Kansal ceased to be Additional Director on 14 Aug 2020. Manoj Goyal was appointed as Director on 13 Aug 2020. I B Pharma has 8 board changes on record in total.
Yes, I B Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-08-0010135).
I B Pharma can be reached through the website ibpharma.in. Its registered office is in New Delhi, Delhi, India.